center for brca & related genes 2022 scientific symposium | morning session
Published 1 year ago • 896 plays • Length 2:26:18Download video MP4
Download video MP3
Similar videos
-
2:31:24
center for brca & related genes 2022 scientific symposium | afternoon session
-
1:00:03
leading the way in cancer detection, treatment and prevention: the center for brca and related genes
-
50:25
synthetic lethal interactions of brca1 in stalled-fork repair | 2023 brca scientific symposium
-
41:46
haploinsufficient phenotypes of brca1/2-mutant breast tissue | 2023 brca scientific symposium
-
43:40
health literacy & barriers to engaging people in clinical trials | 2023 brca scientific symposium
-
35:40
understanding brca 1/2 cancer risk | dana-farber cancer institute
-
52:51
considering brca genes in breast cancer
-
1:08:58
tnbc current and emerging therapeutic strategies | 2023 best of breast conference
-
6:41
a guide to brca1 and brca2 gene mutations in hereditary breast and ovarian cancer
-
2:13
dr. judy garber on genetic testing for brca / dana-farber cancer institute
-
1:01
when should children of brca mutation carriers undergo genetic testing? | dana-farber
-
8:37
brca1 and brca2 mutations & cancer (types of cancer, and who’s most at risk)
-
45:28
ddr deficiency and replication stress in pancreatic cancer | 2023 brca scientific symposium
-
26:38
live webchat: the truth about brca testing and genetic risk
-
5:10
genetic counseling for cancer risk: what to expect | dana-farber cancer institute
-
4:53
what are germline and somatic mutations? | dana-farber cancer institute
-
2:11
how can i prevent cancer if i have a brca mutation? | dana-farber cancer institute
-
31:55
lynch syndrome and less common cancers | dana-farber cancer institute
-
52:15
understanding and overcoming parp inhibitor resistance
-
1:50
asco22: breast cancer research by chris labaki, md | dana-farber cancer institute
-
28:57
2021 force | hereditary cancer | cancer risks, screening & prevention for brca1 or brca2 mutations
-
1:53
how is personalized medicine used in women's cancers? | dana-farber cancer institute